Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZUBSOLV® safely and effectively. See full prescribing information for ZUBSOLV. ZUBSOLV (buprenorphine and naloxone sublingual tablets), CIII Initial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
ZUBSOLV is indicated for treatment of opioid dependence. ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support.
- generic_name
- buprenorphine hydrochloride and naloxone hydrochloride
- product_names
- buprenorphine hydrochloride and naloxone hydrochloride
- ndc
- 82111-201, 82111-201-30, 82111-202, 82111-202-30, 82111-203, 82111-203-30, 82111-204, 82111-204-30, 82111-205, 82111-205-30, 82111-206, 82111-206-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en